Usui Yoshihiko, Kinouchi Reiko, Nakano Satoko, Iwahashi Chiharu, Hase Keitaro, Nagata Kenji, Sugimoto Masahiro, Hasegawa Eiichi, Tsubota Kinya, Kusuhara Sentaro, Akiyama Masato, Kashiwagi Kenji, Takeda Atsunobu, Kaburaki Toshikatsu, Goto Hiroshi, Sonoda Koh-Hei
Department of Ophthalmology, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan.
Department of Ophthalmology, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
PLoS One. 2025 May 23;20(5):e0323822. doi: 10.1371/journal.pone.0323822. eCollection 2025.
Acute retinal necrosis (ARN) is a rare but vision-threatening viral retinitis that can lead to severe visual impairment or blindness if not diagnosed and treated promptly. However, due to its rarity, there are limited large-scale data on the clinical characteristics, treatment approaches, and outcomes of ARN in Japan. A nationwide registry is needed to systematically collect data on ARN cases across Japan to improve understanding of this condition and optimize patient care. We have designed a national registry that collects data of patient characteristics, diagnosis, treatment, and visual outcome to generate evidence for the management of ARN.
This research is a combined retrospective and prospective, multicenter cohort study of ARN in Japan from 1 April 2014-31 March 2029 (UMIN000056246). The registry has received Japan-wide approval from a national human research ethics committee. The following data will be collected: patient demographics, visual function at the initial visit and 6, 12, 24, and 36 months later, image data, diagnostic methods, virus analysis, indications and timing of vitrectomy, and complications. Customized software and platforms have been designed to permit data collection for a single baseline and multiple follow-up forms.
By analyzing the accumulated patient information, the results of this study will generate real-world evidence that will contribute to solve various important clinical issues in ARN. The results will be presented after data collection and analysis are completed.
急性视网膜坏死(ARN)是一种罕见但可威胁视力的病毒性视网膜炎,如果不及时诊断和治疗,可导致严重视力损害或失明。然而,由于其罕见性,日本关于ARN的临床特征、治疗方法和预后的大规模数据有限。需要一个全国性登记系统来系统收集日本各地ARN病例的数据,以增进对这种疾病的了解并优化患者护理。我们设计了一个全国性登记系统,收集患者特征、诊断、治疗和视力预后的数据,以生成ARN管理的证据。
本研究是一项对2014年4月1日至2029年3月31日期间日本ARN患者的回顾性和前瞻性相结合的多中心队列研究(UMIN000056246)。该登记系统已获得全国人类研究伦理委员会在全日本范围内的批准。将收集以下数据:患者人口统计学信息、初诊时以及6、12、24和36个月后的视力功能、图像数据、诊断方法、病毒分析、玻璃体切除术的指征和时机以及并发症。已设计定制软件和平台,以允许收集单一基线和多个随访表格的数据。
通过分析积累的患者信息,本研究结果将产生真实世界的证据,有助于解决ARN中的各种重要临床问题。结果将在数据收集和分析完成后公布。